President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to ...

A gene-editing therapy for sickle cell disease, with a price tag of £1.65m, is to be offered to patients on the NHS in England. About 50 people a year with the inherited blood disorder are likely ...

The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts say.

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Asiawu Imam says the therapy will make a huge difference A gene-editing therapy for sickle cell disease, with a price tag of £1.65m, is to be offered to patients on the NHS in England.

Vertex Pharmaceuticals (VRTX) stock gains as England opts to reimburse its CRSPR (CRSP)-partnered gene therapy Casgevy to ...

There are 20 cell and gene therapies on Europe's market versus 43 in the U.S. Find out more about this ecosystem.

Vertex Pharmaceuticals Inc. (VRTX), a commercial-stage global biotechnology company, announced Friday a reimbursement agreement with ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...

Cell therapy is a field rife with innovation ... We have the capability really of transforming in vivo gene therapy in general as we move forward and get proof of concept.” ...

Company prepares to advance to Phase 2 clinical trial in early 2025HOUSTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- March Biosciences (March Bio), an ...